<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="Publisher" Owner="NLM">        <PMID Version="1">30102019</PMID>        <DateRevised>            <Year>2018</Year>            <Month>08</Month>            <Day>19</Day>        </DateRevised>        <Article PubModel="Print-Electronic">            <Journal>                <ISSN IssnType="Electronic">1754-9485</ISSN>                <JournalIssue CitedMedium="Internet">                    <PubDate>                        <Year>2018</Year>                        <Month>Aug</Month>                        <Day>13</Day>                    </PubDate>                </JournalIssue>                <Title>Journal of medical imaging and radiation oncology</Title>                <ISOAbbreviation>J Med Imaging Radiat Oncol</ISOAbbreviation>            </Journal>            <ArticleTitle>Utility of CT imaging in a novel form of high-dose-rate intraoperative breast radiation therapy.</ArticleTitle>            <ELocationID EIdType="doi" ValidYN="Y">10.1111/1754-9485.12790</ELocationID>            <Abstract>                <AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Intraoperative radiation therapy (IORT) is an alternative to whole breast radiation following breast conserving surgery. Conventional breast IORT is limited by lack of cross-sectional imaging. In response, our institution developed Precision Breast IORT (PB-IORT) which utilizes intraoperative computed tomography (CT) images for confirmation of brachytherapy applicator placement and for treatment planning. The purpose of this study was to determine the utility of CT imaging in PB-IORT in the first 103 patients treated in two prospective clinical trials.</AbstractText>                <AbstractText Label="METHODS" NlmCategory="METHODS">We retrospectively reviewed the first 103 patients treated with PB-IORT. All patients underwent breast surgery and placement of a multi-lumen brachytherapy applicator. Patients had a CT scan followed by high-dose-rate (HDR) brachytherapy. Endpoints were the number of patients having more than one CT during PB-IORT and the number of treatment plans having image-based modifications.</AbstractText>                <AbstractText Label="RESULTS" NlmCategory="RESULTS">After initial CT scan, 27 patients (26.2%) had findings prompting surgical applicator adjustment. One patient underwent an additional scan to localize a biopsy clip and aid in excision to negative margin. Eighty-one patients (78.6%) had dosimetry modifications based on CT findings with 36 plans (35.0%) adjusted to protect the skin or chest wall and 45 plans (43.7%) to protect both the skin and chest wall.</AbstractText>                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Computed tomography findings prompted treatment alterations in the majority of patients treated with PB-IORT to enhance tissue conformity and to sculpt the radiation dose away from normal tissues. CT imaging is unique to PB-IORT. These findings suggest the potential clinical superiority of PB-IORT given its allowance for patient-specific alterations.</AbstractText>                <CopyrightInformation>© 2018 The Royal Australian and New Zealand College of Radiologists.</CopyrightInformation>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Hassinger</LastName>                    <ForeName>Taryn E</ForeName>                    <Initials>TE</Initials>                    <Identifier Source="ORCID">http://orcid.org/0000-0003-3015-4126</Identifier>                    <AffiliationInfo>                        <Affiliation>Division of Surgical Oncology, Department of Surgery, University of Virginia School of Medicine, Charlottesville, Virginia, USA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Showalter</LastName>                    <ForeName>Timothy N</ForeName>                    <Initials>TN</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Radiation Oncology, University of Virginia School of Medicine, Charlottesville, Virginia, USA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Schroen</LastName>                    <ForeName>Anneke T</ForeName>                    <Initials>AT</Initials>                    <AffiliationInfo>                        <Affiliation>Division of Surgical Oncology, Department of Surgery, University of Virginia School of Medicine, Charlottesville, Virginia, USA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Brenin</LastName>                    <ForeName>David R</ForeName>                    <Initials>DR</Initials>                    <AffiliationInfo>                        <Affiliation>Division of Surgical Oncology, Department of Surgery, University of Virginia School of Medicine, Charlottesville, Virginia, USA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Berger</LastName>                    <ForeName>Adam C</ForeName>                    <Initials>AC</Initials>                    <AffiliationInfo>                        <Affiliation>Section of Surgical Oncology, Department of Surgery, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Libby</LastName>                    <ForeName>Bruce</ForeName>                    <Initials>B</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Radiation Oncology, University of Virginia School of Medicine, Charlottesville, Virginia, USA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Showalter</LastName>                    <ForeName>Shayna L</ForeName>                    <Initials>SL</Initials>                    <AffiliationInfo>                        <Affiliation>Division of Surgical Oncology, Department of Surgery, University of Virginia School of Medicine, Charlottesville, Virginia, USA.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <GrantList CompleteYN="Y">                <Grant>                    <GrantID>T32 CA163177</GrantID>                    <Acronym>CA</Acronym>                    <Agency>NCI NIH HHS</Agency>                    <Country>United States</Country>                </Grant>            </GrantList>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>08</Month>                <Day>13</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>Australia</Country>            <MedlineTA>J Med Imaging Radiat Oncol</MedlineTA>            <NlmUniqueID>101469340</NlmUniqueID>            <ISSNLinking>1754-9477</ISSNLinking>        </MedlineJournalInfo>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N">breast conservation therapy</Keyword>            <Keyword MajorTopicYN="N">breast neoplasms</Keyword>            <Keyword MajorTopicYN="N">intraoperative care</Keyword>            <Keyword MajorTopicYN="N">radiotherapy</Keyword>            <Keyword MajorTopicYN="N">radiotherapy, image-guided</Keyword>        </KeywordList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="received">                <Year>2018</Year>                <Month>03</Month>                <Day>01</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="accepted">                <Year>2018</Year>                <Month>07</Month>                <Day>18</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>8</Month>                <Day>14</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>8</Month>                <Day>14</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>8</Month>                <Day>14</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>aheadofprint</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30102019</ArticleId>            <ArticleId IdType="doi">10.1111/1754-9485.12790</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>